Postmastectomy radiation therapy in T3 node-negative breast cancer

Area of Science:

• Oncology
• Radiation Oncology
• Surgical Oncology

Background:

• Tumor size is a key prognostic factor in node-negative breast cancer.
• The role of postmastectomy radiation therapy (PMRT) in T3 node-negative breast cancer remains controversial.
• This study addresses the clinical utility of PMRT in this specific patient group.

Purpose of the Study:

• To investigate the impact of PMRT on survival outcomes in women with T3 node-negative breast cancer.
• To determine if PMRT offers a clinical benefit for this population.
• To analyze breast cancer-specific survival in relation to PMRT use.

Main Methods:

• Retrospective cohort study using the Surveillance, Epidemiology and End Results (SEER) database (1988-2009).
• Identified 2874 women with T3 node-negative breast cancer.
• Utilized Kaplan-Meier survival analysis, Cox proportional hazard ratios, and propensity score analysis to evaluate survival outcomes.

Main Results:

• 33% of patients received PMRT; significant differences in PMRT use were observed based on patient and tumor characteristics.
• Unadjusted and adjusted analyses showed no significant difference in overall survival between PMRT and non-PMRT groups.
• Both unadjusted and propensity score-adjusted analyses revealed no significant difference in breast cancer-specific survival based on PMRT use.

Conclusions:

• The use of PMRT in T3 node-negative breast cancer does not appear to provide a clinical benefit.
• SEER database analysis suggests PMRT is not associated with improved survival in this patient cohort.
• Further research may be warranted, but current evidence does not support routine PMRT for T3 node-negative breast cancer.